Cerebral DWI lesion burden following carotid artery stenting with guided antiplatelet therapy: a retrospective comparative study
Open Access
- 29 May 2026
- journal article
- Published by Springer Nature in CVIR Endovascular
- Vol. 9 (1)
Abstract
Purpose: To analyze the number, location, and clinical significance of new ischemic lesions (NIL) after carotid stenting in patients with guided antiplatelet therapy. To evaluate factors leading to thromboembolic complications and silent ischemia. Secondarily, we compared the incidence of NIL among historical cohorts with guided and standard antiplatelet therapy. Methods: We conducted a retrospective analysis of prospectively collected data from 171 patients who underwent carotid stenting in a single center between 2014 and 2023. Magnetic resonance imaging with diffusion-weighted images was performed before and after stenting. We evaluated NIL after the procedure and their dependence on patient demographics, degree of stenosis, instrumentation used, and antiplatelet therapy. The incidence of NIL was compared to three cohorts receiving more potent or guided antiplatelet therapy based on platelet function test ( n = 689) and to seven cohorts receiving standard dual antiplatelet therapy with aspirin and clopidogrel ( n = 2777), using the meta-analytical approach. Results: New ischemic lesions were found in 15.8% of patients (27/171). We recorded five ischemic strokes (2.9%). Most NIL were located in the ipsilateral middle cerebral artery basin (91%), but they also occurred contralaterally or in another basin. Stenosis length ≥ 15 mm ( p = 0.012) was shown to be significantly associated with the development of NIL. The incidence of NIL in a center with guided antiplatelet therapy was distinctly lower compared to results of the studies with standard antiplatelet therapy, 15.8% vs. 28.3–51.3%. Conclusion: Guided antiplatelet therapy in carotid stenting is safe and shows a lower incidence of new ischemic lesions on MR-DWI compared to results with standard antiplatelet therapy. In this study with guided antiplatelet therapy, NIL were only associated with greater stenosis length.Keywords
Funding Information
- Cooperatio Program (Research area Cardiovascular Science)
- Grant by Krajská zdravotní a.s.: (IGA-KZ-2023-1-10.)
This publication has 33 references indexed in Scilit:
- Carotid Artery StentingJACC, 2022
- Editor's Choice – European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery DiseaseEuropean Journal of Vascular and Endovascular Surgery, 2022
- Predictors of Ipsilateral New Ischemic Lesions on Diffusion-Weighted Imaging after Carotid Artery Stenting in Asymptomatic Patients: A Retrospective Observational Study with Conventional Multicontrast MRIAnnals of Vascular Surgery, 2021
- Age and the risk of new ischemic lesions on diffusion weighted imaging after carotid artery stenting: A systematic review and meta-analysisClinical Neurology and Neurosurgery, 2020
- Risk factors for silent new ischemic cerebral lesions following carotid artery stentingNeuroradiology, 2020
- Editor's Choice – Predictors of New Ischaemic Brain Lesions on Diffusion Weighted Imaging After Carotid Stenting and Endarterectomy: A Systematic ReviewEuropean Journal of Vascular and Endovascular Surgery, 2019
- A meta-analysis of the effect of stent design on clinical and radiologic outcomes of carotid artery stentingJournal of Vascular Surgery, 2019
- Ischemic Brain Lesions After Carotid Artery Stenting Increase Future Cerebrovascular RiskJACC, 2015
- Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trialThe Lancet, 2015
- Impact of Asymptomatic Cerebral Lesions in Diffusion-Weighted Magnetic Resonance Imaging After Carotid Artery StentingJACC: Cardiovascular Interventions, 2013